BIDU-SW
09888
BOSS ZHIPIN-W
02076
NTES-S
09999
4
BABA-W
09988
5
TENCENT
00700
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 1.53%1.39B | -3.17%5.26B | 0.14%4.07B | 4.52%2.83B | 5.55%1.37B | -24.05%5.43B | -24.69%4.06B | -27.96%2.71B | -31.90%1.3B | 12.44%7.15B |
Operating income | 1.53%1.39B | -3.17%5.26B | 0.14%4.07B | 4.52%2.83B | 5.55%1.37B | -24.05%5.43B | -24.69%4.06B | -27.96%2.71B | -31.90%1.3B | 12.44%7.15B |
Cost of sales | ---- | 21.61%-3.52B | ---- | -4.70%-1.83B | ---- | 7.63%-4.49B | ---- | 31.15%-1.75B | ---- | -11.33%-4.86B |
Operating expenses | -12.62%-1.01B | 21.61%-3.52B | 0.10%-2.72B | -4.70%-1.83B | -6.21%-899.55M | 7.63%-4.49B | 25.55%-2.72B | 31.15%-1.75B | 36.37%-846.99M | -11.33%-4.86B |
Gross profit | -19.53%381.18M | 84.86%1.74B | 0.63%1.35B | 4.20%999.27M | 4.33%473.7M | -58.92%940.9M | -22.87%1.34B | -21.30%958.96M | -21.61%454.03M | 14.88%2.29B |
Selling expenses | -1.26%-93.47M | 24.73%-389.44M | 30.26%-280.98M | 38.19%-191.91M | 45.34%-92.31M | 0.21%-517.42M | -9.16%-402.92M | -27.48%-310.49M | -40.39%-168.88M | -20.44%-518.5M |
Administrative expenses | -9.08%-97.73M | 5.35%-638.47M | -0.90%-309M | 13.25%-279.61M | 19.87%-89.6M | 9.15%-674.55M | 5.06%-306.24M | -8.13%-322.3M | -15.44%-111.82M | -11.09%-742.46M |
Research and development expenses | -13.31%-39.99M | ---- | 14.61%-129.98M | ---- | -33.11%-35.29M | ---- | 8.63%-152.22M | ---- | -26.96%-26.51M | ---- |
Profit from asset sales | 4,404.34%1.29M | ---- | 212.88%620.16K | ---- | -71.48%28.61K | ---- | -170.69%-549.39K | ---- | 73.94%100.32K | ---- |
Revaluation surplus | -264.01%-45.3M | ---- | -364.77%-98.35M | ---- | 161.07%27.62M | ---- | 351.88%37.14M | ---- | -82.62%10.58M | ---- |
-Changes in the fair value of other assets | -264.01%-45.3M | ---- | -364.77%-98.35M | ---- | 161.07%27.62M | ---- | 351.88%37.14M | ---- | -82.62%10.58M | ---- |
Impairment and provision | -98.66%520.27K | -37.52%-199.42M | 1,499.13%39.24M | 371.10%11.45M | 296.86%38.78M | -137.48%-145.02M | 111.37%2.45M | 54.37%-4.22M | 188.75%9.77M | 81.21%-61.07M |
-Impairment of property, machinery and equipment | ---- | -24.37%-55.37M | ---- | ---- | ---- | ---44.52M | ---- | ---- | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---68.16M | ---- | ---- | ---- | ---- |
-Other impairment is provision | -98.66%520.27K | -345.33%-144.06M | 1,499.13%39.24M | 371.10%11.45M | 296.86%38.78M | 47.03%-32.35M | 111.37%2.45M | 54.37%-4.22M | 188.75%9.77M | 81.21%-61.07M |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -16.92%-245.63M |
Special items of operating profit | 138.51%22.48M | 248.61%501.27M | 267.35%425.83M | 91.24%390.72M | -587.74%-58.38M | -30.13%143.79M | -417.16%-254.45M | 46.49%204.3M | 56.94%-8.49M | 1,300.25%205.78M |
Operating profit | -52.82%122.47M | 501.61%1.01B | 289.94%986.44M | 76.71%929.92M | 68.26%259.58M | -127.18%-252.3M | -67.91%252.97M | -23.07%526.24M | -58.15%154.28M | 171.05%928.31M |
Financing cost | 190.08%56.51M | 36.34%-145.21M | -11.88%-82.96M | 33.06%-84.5M | 22.20%-62.73M | ---228.09M | -238.56%-74.15M | ---126.23M | 5.30%-80.63M | ---- |
Share of profits of associates | ---- | 68.34%-141.82M | ---- | 66.52%-77.77M | ---- | -354.95%-447.95M | ---- | -322.41%-232.29M | ---- | 18.11%-98.46M |
Adjustment items of earning before tax | 95.26%-741.05K | ---- | -790.93%-16.27M | ---- | -500.17%-15.64M | ---- | 387.62%2.36M | ---- | 564.75%3.91M | ---- |
Earning before tax | -1.64%178.24M | 178.23%726.23M | 389.69%887.2M | 357.67%767.65M | 133.64%181.21M | -211.87%-928.33M | -78.46%181.17M | -73.34%167.73M | -72.56%77.56M | 273.36%829.85M |
Tax | 17.05%-22.07M | -180.29%-101.31M | -175.25%-108.14M | -131.06%-104.81M | -129.20%-26.61M | 209.56%126.18M | 79.43%-39.29M | 61.76%-45.36M | 75.51%-11.61M | -1,135.65%-115.16M |
After-tax profit from continuing operations | 1.02%156.17M | 177.90%624.92M | 449.08%779.06M | 441.68%662.84M | 134.42%154.6M | -212.24%-802.16M | -78.17%141.89M | -76.03%122.37M | -71.97%65.95M | 206.23%714.69M |
Earning after tax | 1.02%156.17M | 177.90%624.92M | 449.08%779.06M | 441.68%662.84M | 134.42%154.6M | -212.24%-802.16M | -78.17%141.89M | -76.03%122.37M | -71.97%65.95M | 206.23%714.69M |
Minority profit | 4.84%-421K | -15.46%-21.82M | 17.91%-1.05M | 13.73%-848K | 25.19%-442.43K | -52.55%-18.9M | 41.45%-1.28M | -33.56%-983K | -299.90%-591.38K | -67.34%-12.39M |
Profit attributable to shareholders | 1.00%156.59M | 182.57%646.74M | 444.89%780.11M | 438.05%663.68M | 133.00%155.04M | -207.73%-783.26M | -78.05%143.17M | -75.87%123.35M | -71.68%66.54M | 201.96%727.08M |
Basic earnings per share | 0.95%0.1067 | 183.02%0.44 | 444.77%0.5317 | 462.50%0.45 | 133.33%0.1057 | -206.00%-0.53 | -78.04%0.0976 | -77.14%0.08 | -71.71%0.0453 | 212.50%0.5 |
Diluted earnings per share | 0.95%0.1067 | 183.02%0.44 | 444.77%0.5317 | 462.50%0.45 | 133.33%0.1057 | -206.00%-0.53 | -78.04%0.0976 | -77.14%0.08 | -71.71%0.0453 | 212.50%0.5 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | -- | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.